A unique protein epitope, created by alternative-splicing of the CIZ1 gene, is present in the plasma fraction of blood from patients with lung cancer, making it a strong candidate for high impact, high throughput early detection of lung cancer. Here, CIZ1 is linked to lung carcinoma.